Volume Alert - VRX 136.16 Valeant Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 11:27 AM

Volume Alert - VRX 136.16 Valeant Pharmaceuticals International $VRX Hit a high today of 136.50 Closing the day 10:30 at 136.16 +1.95 +1.45% With a day low of 132.73 and a total volume of 3,820,934.

VRX Recent Posts: http://investorshangout.com/Valeant-Pharmaceu...VRX-53038/

VRX Valeant Pharmaceuticals International Recent Headline News

Allergan's $66 Billion Actavis Deal is Still a Win for Bill Ackman
at The Street - 28 mins ago
Valeant says it can't justify $219 a share offer to shareholders.
ZTS: 43.91 (+0.77), AGN: 210.73 (+12.08), VRX: 135.65 (+1.44), ACT: 248.52 (+4.75)

Actavis to spend $66B on Allergan
By TOM MURPHY - AP - 40 mins ago
Actavis will pay $66 billion to buy fellow drugmaker Allergan in a deal that could finally end a months-long takeover push from Valeant Pharmaceuticals for the Botox maker.
DRTX: 23.94 (+0.19), AGN: 210.73 (+12.08), ACT: 248.52 (+4.75), VRX: 135.65 (+1.44), VRX.TO: 153.39 (+1.92)

Actavis Nabs Allergan For $66 Billion; Valeant Folds
at Investor's Business Daily - 1 hr 10 mins ago
One of the most widely rumored deals in pharma came to fruition Monday, as Actavis (ACT) agreed to acquire Allergan (AGN) for $66 billion in cash and stock. Allergan stock was up more than 7%, near 213, and Actavis stock up nearly 4%, near 253, in...
AGN: 210.73 (+12.08), VRX: 135.65 (+1.44), ACT: 248.45 (+4.68)

Time to move on: Valeant chief says $219 too rich
Seeking Alpha - at Seeking Alpha - 1 hr 13 mins ago

ACT: 248.45 (+4.68), VRX: 135.65 (+1.44)

Valeant Comments On Allergan Announcement
PR Newswire - 1 hr 58 mins ago
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today commented on the announcement that Allergan, Inc. (NYSE: AGN) and Actavis plc (NYSE: ACT) have entered into a definitive agreement under which Actavis will acquire all outstanding shares of Allergan stock.
AGN: 210.77 (+12.12), ACT: 248.58 (+4.81), VRX: 135.65 (+1.44), VRX.TO: 153.39 (+1.92)

Stock Futures Set For Weak Open; Halliburton, Baker Hughes Merge
at Investor's Business Daily - 2 hrs 15 mins ago
Stock futures pointed modestly lower ahead of Monday's open as merger news stirred some of the most notable premarket stock moves. Dow futures sifted 27.7 points below fair market value. Nasdaq 100 futures were 9.1 points lower, and S&P 500 futures...
AGN: 210.77 (+12.12), HAS: 56.31 (+2.29), VRX: 135.65 (+1.44), ACT: 248.64 (+4.87), HAL: 50.68 (-4.40), DIS: 90.31 (-0.49), DWA: 22.28 (-3.74), BHI: 66.73 (+6.84)

Today's Market: Pharma And Tech Companies In Focus This Morning
Matthew Smith - at Seeking Alpha - 2 hrs 20 mins ago

AGN: 210.77 (+12.12), VRX: 135.65 (+1.44), ACT: 248.63 (+4.86), LNKD: 222.45 (-11.44), FB: 74.13 (-0.75), MSFT: 49.26 (-0.32), GOOG: 534.89 (-9.51)

Actavis Rumored to be Close to Acquiring Allergan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 27 mins ago
As per market rumors, Actavis (ACT) is closing in on a deal to acquire Allergan (AGN) for over $65.5 billion.
DRTX: 23.94 (+0.19), ZTS: 43.91 (+0.77), AGN: 210.77 (+12.12), ACT: 248.58 (+4.81), VRX: 135.65 (+1.44)

Tracking Bill Ackman's Pershing Square Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Mon Nov 17, 6:40AM CST

ZTS: 43.91 (+0.77), AGN: 210.77 (+12.12), HLF: 38.48 (-0.02), VRX: 135.65 (+1.44), ACT: 248.64 (+4.87), HHC: 142.97 (-0.71), PAH: 25.70 (+0.20), CP: 204.86 (+0.30), APD: 134.99 (+0.28), BKW: 32.05 (-0.24)

Wall Street Breakfast: Nikkei Dives As Japan Slips Into Recession
Wall Street Breakfast - Seeking Alpha - Mon Nov 17, 5:30AM CST
Outstanding Performance Article Rewards We're excited to announce our latest two Outstanding Performance award winners. Each author receives $2,500. Read more about our Outstanding Performance award winners here . Winner #1: Top long idea...
VRX: 135.65 (+1.44), ACT: 248.64 (+4.87), F: 15.35 (+0.21), FB: 74.13 (-0.75), PFE: 29.95 (-0.39), AGN: 210.79 (+12.14), YHOO: 51.35 (-0.40), PBR: 9.61 (-0.34), DFS: 64.86 (-0.12), DTSI: 32.78 (-0.25), SPY: 203.88 (-0.36), LNKD: 222.45 (-11.44), QQQ: 102.51 (-0.71), AME: 51.12 (-0.58), MRK: 59.71 (+0.64), AOL: 46.28 (+0.24), AZN: 72.14 (-0.71), GM: 32.16 (+0.37), CVEO: 10.53 (-0.11), DD: 70.50 (-0.30)

Actavis near deal to acquire Allergan for $210-220/share
Seeking Alpha - at Seeking Alpha - Sun Nov 16, 2:51PM CST

AGN: 210.79 (+12.14), ACT: 248.64 (+4.87), VRX: 135.65 (+1.44)

Tracking Lou Simpson's SQ Advisors Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Sun Nov 16, 10:03AM CST

BAM: 49.79 (+0.18), VRX: 135.65 (+1.44), LBTYK: 45.43 (-0.57), CCK: 48.22 (+0.68), WFC: 53.21 (-0.14), ORCL: 40.93 (+0.09), UPS: 106.40 (-0.43), MCO: 100.43 (-0.04), T: 35.84 (-0.06), USB: 43.75 (+0.02), TEL: 60.90 (-0.63), DTV: 87.22 (-0.33), BRK.B: 145.40 (-0.12), BRK.A: 218,035.00 (+12.00), SCHW: 28.57 (-0.30)

Tracking Glenn Greenberg's Brave Warrior Advisors Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Sat Nov 15, 10:45AM CST

KMI: 39.78 (+0.41), VRX: 135.65 (+1.44), HAL: 50.69 (-4.39), KMP: 97.14 (+0.89), BAC: 17.11 (-0.03), TDW: 37.56 (-0.23), VPRT: 67.60 (+0.80), ORCL: 40.93 (+0.09), PRI: 51.71 (-0.34), EPB: 41.87 (+0.42), ESRX: 78.35 (+0.48), EQIX: 221.58 (-0.51), JPM: 60.28 (unch), KMR: 98.09 (+1.13), MSFT: 49.26 (-0.32), CMCSA: 54.12 (+0.02), SCHW: 28.57 (-0.30)

After Yesterday's Rally of 1.80% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Nov 14, 3:59PM CST
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $131.34 to a high of $134.64. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $133.84 on volume of 2.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
VRX: 135.65 (+1.44)

Merck KGaA Q3 Earnings Rise Y/Y, 2014 View Upgraded - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 1:20PM CST
Merck KGaA (MKGAF) reported third-quarter 2014 earnings of $1.53 per American Depositary Receipt (ADR), up 0.2% from the year-ago quarter.
LCI: 47.36 (+0.48), VRX: 135.65 (+1.44), ADHD: 3.45 (-0.21)

Valeant Should Drop Allergan Bid And Go For Zoetis
Kanak Kanti De - at Seeking Alpha - Fri Nov 14, 7:30AM CST

ZTS: 43.91 (+0.77), AGN: 210.85 (+12.20), VRX: 135.65 (+1.44), ACT: 248.67 (+4.90)

Will Actavis Snatch Allergan, Valeant Settle for Zoetis? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 4:28PM CST
A report from Bloomberg stated that Actavis is in discussions to Allergan for a deal worth at least $60 billion.
ZTS: 43.91 (+0.77), AGN: 210.85 (+12.20), ACT: 248.67 (+4.90), VRX: 135.65 (+1.44)

Valeant Pharmaceuticals Completes Renovation Of U.S. Headquarters In New Jersey
CNW Group - Thu Nov 13, 4:00PM CST
Expansion of its U.S. headquarters solidifies commitment to grow jobs and support the local economy
VRX: 135.65 (+1.44), VRX.TO: 153.39 (+1.92)

Bausch Health Companies Inc. (BHC) Stock Research Links

BHC Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tiger Group to Auction Huge Window Manufacturing Plant

Glass & Vinyl Ambitions: A New Chapter Who would have guessed? The seasoned window maker Showcase Window and Door Company is putting its prime manufacturing facility up for grabs. The online auction, orchestrated by Tiger Group, kicks off September 10, and it's sure to stir up some excitement in the industry. With picking up operations now within reach, it feels like...

Intellectia.AI Transforming Trading with AI Upgrades

Intellectia.AI Sparks New Trading Era Intellectia.AI, from the bustling streets of New York, is cutting through the noise with a flashy update to its AI-powered trading setup. They've thrown a heap of new toys into the ring, letting folks piggyback on high-grade stock moves in the blink of an eye. Gone are the days of fumbling with cumbersome data and execution. Breaking...

Illinois' Legal Tangle: Feds Under Fire?

What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...

India's First Upright Proton Therapy System Unveiled

A Leap Forward in Cancer Care: Proton Therapy Revolution Dang, just when you think you've heard it all in cancer treatment, Fortis Healthcare drops a bombshell: India’s first upright proton therapy system. Boom! This isn't your run-of-the-mill radiation treatment we're talking about here. This is the futuristic flair of the MEVION S250-FIT™, featuring upright...

ASCEND® Cladding Unveils New Profiles & Texture Variety

New Options for Creative Home Exteriors Amid today's housing market rollercoaster, a sprinkle of bold innovation in building materials can make a statement—and that's precisely what Associated Materials Innovations (AMI) is banking on with their latest beef-up in the ASCEND® Composite Cladding lineup. Introduced out of Cuyahoga Falls on Sept. 8, 2026, this expansion...

How Timekettle Is Bridging Language Gaps at IFA 2026

Pioneering AI Innovations in Language Translation Timekettle is making some serious waves at IFA 2026, throwing its hat in the ring with innovations that redefine multilingual interaction. From sleek translation earbuds to full-blown meeting hubs, each gadget screams one thing loud and clear—communication sans language barriers. Centered in the tech extravaganza of...

Life Flower Celebrates 16 Years with Dog Adoption Event

A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...

The Austin Company to Showcase at ISPE Annual Event

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

Stoke Space Raises $1B; XTEND AI Hits NYSE

A Billion-Dollar Boost for Stoke Space Ever catch wind of a company hauling in a cool billion and shrug it off? Me neither. Stoke Space Technologies just locked down $1 billion in Series E funding. This ain't some pocket change—the kind of dough you need when you're eyeing stars and plotting orbital voyages. They're gearing up for a 2027 mission with their Nova...

Mandeville Pests: Health Dangers Lurking at Home

Pest Trouble Brewing in Mandeville: A Health Alert There’s a storm brewing in Mandeville, Louisiana, and it's not the kind you can see rolling in on the horizon. We're talking about those sneaky pests going unnoticed in our homes. Folks, these pests aren't just a nuisance; they're ticking time bombs for public health. Take it from J&J Exterminating, who know a thing or...